Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017, Article ID 6491674, 8 pages
https://doi.org/10.1155/2017/6491674
Research Article

Uptake of 18F-FET and 18F-FCH in Human Glioblastoma T98G Cell Line after Irradiation with Photons or Carbon Ions

1Department of Oncohaematology, Radiotherapy Unit, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy
2Department of Biology and Biotechnology “Lazzaro Spallanzani”, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy
3Department of Oncohaematology, Nuclear Medicine Unit, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy
4Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy
5National Centre for Oncological Hadrontherapy (CNAO), Via Campeggi 53, 27100 Pavia, Italy
6Nuclear Medicine Research Department, IASON GmbH, Graz, Austria

Correspondence should be addressed to Carlo Aprile; ti.vp.oettams@elirpa.c

Received 29 July 2016; Revised 10 November 2016; Accepted 26 December 2016; Published 16 January 2017

Academic Editor: Ralf Schirrmacher

Copyright © 2017 Francesca Pasi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Şen, M. V. Aydin, N. Altinörs, B. Erdoğan, F. Kayaselçuk, and O. Kizilkiliç, “Recurrent tumor or radionecrosis,” Turkish Neurosurgery, vol. 14, no. 1-2, pp. 41–44, 2004. View at Google Scholar · View at Scopus
  2. F. Bayrakli, A. Dinçer, A. Sav, E. Vardareli, and S. Peker, “Late brain stem radionecrosis seventeen years after fractionated radiotherapy,” Turkish Neurosurgery, vol. 19, no. 2, pp. 182–185, 2009. View at Google Scholar · View at Scopus
  3. M. Herrera-Rivero, M. T. Heneka, and V. Papadopoulos, “Translocator protein and new targets for neuroinflammation,” Clinical and Translational Imaging, vol. 3, no. 6, pp. 391–402, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Yoshii, “Pathological review of late cerebral radionecrosis,” Brain Tumor Pathology, vol. 25, no. 2, pp. 51–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Bette, P. Peschke, J. Kaesmacher et al., “Static FET–PET and MR Imaging in Anaplastic Gliomas (WHO III),” World Neurosurgery, vol. 91, pp. 524–531.e1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Bette, J. Gempt, C. Delbridge et al., “Prognostic value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-positron emission tomography imaging for histopathologic characteristics and progression-free survival in patients with low-grade glioma,” World Neurosurgery, vol. 89, pp. 230–239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Testart Dardel, M. Gómez-Río, E. Triviño-Ibáñez, and J. M. Llamas-Elvira, “Clinical applications of PET using C-11/F-18-choline in brain tumours: a systematic review,” Clinical and Translational Imaging, pp. 1–19, 2016. View at Publisher · View at Google Scholar
  8. A. van Waarde and P. H. Elsinga, “Proliferation markers for the differential diagnosis of tumor and inflammation,” Current Pharmaceutical Design, vol. 14, no. 31, pp. 3326–3339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Bolcaen, B. Descamps, K. Deblaere et al., “18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET), and 18F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study,” Nuclear Medicine and Biology, vol. 42, no. 1, pp. 38–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Stöber, U. Tanase, M. Herz, C. Seidl, M. Schwaiger, and R. Senekowitsch-Schmidtke, “Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 8, pp. 932–939, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Rossi, “The National Centre for Oncological Hadrontherapy (CNAO): status and perspectives,” Physica Medica, vol. 31, no. 4, pp. 333–351, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Facoetti, B. Vischioni, M. Ciocca et al., “In Vivo radiobiological assessment of the new clinical carbon ion beams at CNAO,” Radiation Protection Dosimetry, vol. 166, no. 1-4, Article ID ncv145, pp. 379–382, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Clark, Staining Procedures, Williams & Wilkins, Baltimore, Md, USA, 3rd edition, 1973.
  14. G. Mazzini, C. Ferrari, and E. Erba, “Dual excitation multi-fluorescence flow cytometry for detailed analyses of viability and apoptotic cell transition,” European Journal of Histochemistry, vol. 47, no. 4, pp. 289–298, 2003. View at Google Scholar · View at Scopus
  15. F. E. Buroni, F. Pasi, M. G. Persico, L. Lodola, C. Aprile, and R. Nano, “Evidence of 18F-FCH uptake in human T98G glioblastoma cells,” Anticancer Research, vol. 35, no. 12, pp. 6439–6444, 2015. View at Google Scholar · View at Scopus
  16. F. F. Calabria, M. Barbarisi, V. Gangemi, G. Grillea, and G. L. Cascini, “Molecular imaging of brain tumors with radiolabeled choline PET,” Neurosurgical Review, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. M. G. Persico, F. E. Buroni, F. Pasi et al., “18F-FET and 18F-FCH uptake in human glioblastoma T98G cell lines,” Radiology and Oncology, vol. 50, no. 2, pp. 153–158, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Spaeth, M. T. Wyss, B. Weber et al., “Uptake of 18F-fluorocholine, 18F-fluoroethyl-L- tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence,” Journal of Nuclear Medicine, vol. 45, no. 11, pp. 1931–1938, 2004. View at Google Scholar · View at Scopus
  19. M. D. Piroth, M. Pinkawa, R. Holy et al., “Prognostic value of early [18F] Fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme,” International Journal of Radiation Oncology Biology Physics, vol. 80, no. 1, pp. 176–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Cherubini, V. de Nadal, and S. Gerardi, “Hyper-radiosensitivity and induced radioresistance and bystander effects in rodent and human cells as a function of radiation quality,” Radiation Protection Dosimetry, vol. 166, no. 1-4, Article ID ncv294, pp. 137–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Besse, J. Sana, R. Lakomy et al., “MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response,” Tumor Biology, vol. 37, no. 6, pp. 7719–7727, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Furuse, N. Nonoguchi, S. Kawabata, S.-I. Miyatake, and T. Kuroiwa, “Delayed brain radiation necrosis: pathological review and new molecular targets for treatment,” Medical Molecular Morphology, vol. 48, no. 4, pp. 183–190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Millet, C. Granotier, O. Etienne, and F. D. Boussin, “Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines,” International Journal of Oncology, vol. 43, no. 2, pp. 375–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bansal, W. Shuyan, T. Hara, R. A. Harris, and T. R. DeGrado, “Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 6, pp. 1192–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Taguchi, M. Inazu, I. Saiki et al., “Functional analysis of [methyl-3H]choline uptake in glioblastoma cells: influence of anti-cancer and central nervous system drugs,” Biochemical Pharmacology, vol. 88, no. 3, pp. 303–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Habermeier, J. Graf, B. F. Sandhöfer, J.-P. Boissel, F. Roesch, and E. I. Closs, “System l amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-l-tyrosine (FET),” Amino Acids, vol. 47, no. 2, pp. 335–344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Galldiks, G. Stoffels, C. P. Filss et al., “Role of O-(2-18F-Fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis,” Journal of Nuclear Medicine, vol. 53, no. 9, pp. 1367–1374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Jeong Cheon, H.-K. Chung, J.-A. Choi et al., “Cellular metabolic responses of PET radiotracers to 188Re radiation in an MCF7 cell line containing dominant-negative mutant p53,” Nuclear Medicine and Biology, vol. 34, no. 4, pp. 425–432, 2007. View at Publisher · View at Google Scholar · View at Scopus